跌幅最大的二十种股份
TOP 20 FALLS - (2022.12)
名次Rank |
代码Code |
股票名称 |
Name of Stocks |
11月收市价Nov. Closing元(Yuan) |
12月收市价Dec. Closing元(Yuan) |
跌幅%%Down |
1 | 300813 | 泰林生物 | ZheJiang Tailin Bioengineering Co.,Ltd | 85.090 | 46.460 | | -45.399 |
2 | 300089 | *ST文化 | The Great Wall Of Culture Group Holding Co.,Lt | 3.300 | 2.150 | | -34.848 |
3 | 301166 | 优宁维 | Shanghai Universal Biotech Co.,Ltd. | 68.900 | 45.730 | | -33.628 |
4 | 300482 | 万孚生物 | GUANGZHOU WONDFO BIOTECH CO.,LTD | 48.000 | 31.870 | | -33.604 |
5 | 300297 | *ST蓝盾 | Bluedon Information Security Technologies Co., | 1.840 | 1.250 | | -32.065 |
6 | 300686 | 智动力 | Shenzhen CDL Precision Technology Co., Ltd. | 17.400 | 12.000 | | -31.034 |
7 | 300495 | *ST美尚 | Misho Ecology & Landscape Co., Ltd. | 3.980 | 2.800 | | -29.648 |
8 | 301235 | 华康医疗 | Wuhan Huakang Century Medical Co., Ltd | 50.820 | 35.770 | | -29.614 |
9 | 301290 | 东星医疗 | Jiangsu Canopus Wisdom Medical Technology Co., | 53.120 | 37.430 | | -29.537 |
10 | 301280 | C珠城 | Zhejiang Zuch Technology Co.,Ltd. | 67.400 | 47.750 | | -29.154 |
11 | 301111 | 粤万年青 | GUANGDONG LIFESTRONG PHARMACY CO., LTD. | 26.580 | 19.620 | | -26.185 |
12 | 300942 | 易瑞生物 | Shenzhen Bioeasy Biotechnology Co., Ltd. | 22.900 | 17.140 | | -25.153 |
13 | 300365 | 恒华科技 | BEIJING FOREVER TECHNOLOGY CO., LTD | 10.100 | 7.610 | | -24.653 |
14 | 301087 | 可孚医疗 | Cofoe Medical Technology Co.,Ltd. | 48.000 | 36.480 | | -24.000 |
15 | 300336 | *ST新文 | SHANGHAI NEW CULTURE MEDIA GROUP CO.,LTD. | 1.850 | 1.410 | | -23.784 |
16 | 301060 | 兰卫医学 | Shanghai Labway Clinical Laboratory Co.,Ltd. | 25.420 | 19.610 | | -22.856 |
17 | 300604 | 长川科技 | Hangzhou Chang Chuan Technology Co.,Ltd. | 57.660 | 44.580 | | -22.685 |
18 | 300534 | 陇神戎发 | Gansu Longshenrongfa Pharmaceutical Industry C | 11.360 | 8.870 | | -21.919 |
19 | 300273 | *ST和佳 | Zhuhai Hokai Medical Instruments Co., Ltd. | 2.580 | 2.020 | | -21.705 |
20 | 300816 | 艾可蓝 | ActBlue Co., Ltd. | 30.750 | 24.400 | | -20.650 |
注: 跌幅 = ( 1 - 本月(年)收市价/(上月(年)收市价*调整因子) ) * 100% |
* : 表示调整因子不为1, 新股以上市首日收市价作为比较基准 |